Brokerages Set Intuitive Surgical, Inc. (NASDAQ:ISRG) Target Price at $396.17

Intuitive Surgical, Inc. (NASDAQ:ISRG) has earned a consensus rating of “Moderate Buy” from the seventeen analysts that are currently covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $396.17.

ISRG has been the topic of a number of research reports. Raymond James lifted their price objective on Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a research note on Thursday, January 25th. Truist Financial upped their price target on shares of Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a research note on Wednesday, January 24th. StockNews.com downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Robert W. Baird lowered their price target on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a report on Friday, April 19th. Finally, Citigroup boosted their price objective on Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd.

Intuitive Surgical Stock Performance

ISRG stock opened at $381.36 on Friday. The company has a market capitalization of $135.27 billion, a PE ratio of 68.84, a price-to-earnings-growth ratio of 4.80 and a beta of 1.39. The company’s fifty day moving average price is $385.56 and its 200-day moving average price is $348.56. Intuitive Surgical has a one year low of $254.85 and a one year high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The business had revenue of $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter in the prior year, the firm earned $1.00 EPS. The business’s revenue was up 11.5% on a year-over-year basis. On average, research analysts predict that Intuitive Surgical will post 4.8 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total transaction of $741,400.00. Following the completion of the sale, the director now owns 25,319 shares in the company, valued at $9,385,753.30. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, President David J. Rosa sold 80,710 shares of the stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $389.28, for a total transaction of $31,418,788.80. Following the completion of the sale, the president now owns 163,399 shares of the company’s stock, valued at $63,607,962.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Alan J. Levy sold 2,000 shares of Intuitive Surgical stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total transaction of $741,400.00. Following the completion of the transaction, the director now directly owns 25,319 shares in the company, valued at $9,385,753.30. The disclosure for this sale can be found here. Insiders have sold a total of 226,928 shares of company stock valued at $87,833,828 over the last ninety days. 0.90% of the stock is owned by company insiders.

Institutional Trading of Intuitive Surgical

A number of institutional investors have recently made changes to their positions in the business. Baystate Wealth Management LLC increased its holdings in shares of Intuitive Surgical by 150.0% during the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 45 shares in the last quarter. MCF Advisors LLC raised its holdings in shares of Intuitive Surgical by 108.1% in the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 40 shares during the last quarter. Able Wealth Management LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $28,000. Atticus Wealth Management LLC grew its holdings in shares of Intuitive Surgical by 85.4% during the fourth quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 41 shares during the last quarter. Finally, MeadowBrook Investment Advisors LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.